AMCANN Research Scientific Publications

AMCANN Research disseminates findings through peer-reviewed literature, theoretical frameworks, and technical communications addressing endocannabinoid biology, anandamide and related signaling compounds, biomarker diagnostics, and translational medicine. Each publication represents a step toward establishing the endocannabinoid system as a routinely measurable clinical framework. Full abstracts, citation export options, and supplementary materials are available for each entry. Researchers and clinicians seeking specific findings or methodological details are encouraged to browse by topic, author, or publication type using the provided filters.

Peer-Reviewed Article

Psychosocial and Biological Aspects of Synthetic and Natural FAAH Inhibitors

David A. Dawson  ·  Edelweiss Journal of Biomedical Research and Review  ·  2019

Examines the psychosocial and biological dimensions of synthetic and naturally occurring FAAH inhibitors, analyzing comparative safety profiles, enzymatic degradation mechanisms, and translational implications for endocannabinoid signaling. Identifies Biochanin A as a promising biologic FAAH inhibitor with a favorable safety profile.

FAAH Regulation Endocannabinoid Signaling Anandamide Biochanin A
Textbook

Medical Cannabis; The Definitive Guide

David A. Dawson, PhD  ·  Yucca Publishing  ·  New York, NY

A comprehensive academic reference covering medicinal cannabis science — from cannabinoid history to endocannabinoid research. Topics include cannabinoid nomenclature, autoimmune disorders, endocannabinoid deficiency, dosing frameworks, strain-specific targeting, and methods of administration.

Endocannabinoid System Autoimmune Disorders Dosing Frameworks Cannabis Chemovars
Book

Pummeled to Death by Hamburger

The Tale of a Man's Lifetime on the Fringes of the Medical Cannabis Industry

David A. Dawson, PhD  ·  Yucca Publishing  ·  New York, NY

A blend of fiction and real-life circumstance following Michael J. Dunston through the medical cannabis industry. Through humor and honesty, Dr. Dawson illuminates the systemic obstacles obstructing legitimate cannabinoid medicine research and patient access.

Medical Cannabis Access Institutional Stigma Patient Advocacy Cannabinoid Medicine